Constellation Energy Corp (CEG)vsNovo Nordisk A/S (NVO)
CEG
Constellation Energy Corp
$303.32
+2.87%
UTILITIES · Cap: $106.82B
NVO
Novo Nordisk A/S
$36.33
-1.52%
HEALTHCARE · Cap: $165.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Novo Nordisk A/S generates 1110% more annual revenue ($309.06B vs $25.53B). NVO leads profitability with a 33.1% profit margin vs 9.1%. CEG appears more attractively valued with a PEG of 3.74. NVO earns a higher WallStSmart Score of 55/100 (C).
CEG
Hold43
out of 100
Grade: D
NVO
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-441.4%
Fair Value
$51.14
Current Price
$303.32
$252.18 premium
Margin of Safety
-59.4%
Fair Value
$24.21
Current Price
$36.33
$12.12 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Attractively priced relative to earnings
Every $100 of equity generates 61 in profit
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 44.5%
Large-cap with strong market position
Areas to Watch
Premium valuation, high expectations priced in
Expensive relative to growth rate
Earnings declined 48.9%
Negative free cash flow — burning cash
Weak financial health signals
Expensive relative to growth rate
Revenue declined 7.6%
Earnings declined 4.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : CEG
The strongest argument for CEG centers on Market Cap. Revenue growth of 12.9% demonstrates continued momentum.
Bull Case : NVO
The strongest argument for NVO centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 33.1% and operating margin at 44.5%.
Bear Case : CEG
The primary concerns for CEG are P/E Ratio, PEG Ratio, EPS Growth.
Bear Case : NVO
The primary concerns for NVO are Piotroski F-Score, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
CEG profiles as a value stock while NVO is a declining play — different risk/reward profiles.
CEG carries more volatility with a beta of 1.11 — expect wider price swings.
CEG is growing revenue faster at 12.9% — sustainability is the question.
CEG generates stronger free cash flow (-181M), providing more financial flexibility.
Bottom Line
NVO scores higher overall (55/100 vs 43/100), backed by strong 33.1% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Constellation Energy Corp
UTILITIES · UTILITIES - INDEPENDENT POWER PRODUCERS · USA
Constellation Energy Corporation is an energy producer in the United States. The company is headquartered in Baltimore, Maryland.
Visit Website →Novo Nordisk A/S
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Compare with Other UTILITIES - INDEPENDENT POWER PRODUCERS Stocks
Want to dig deeper into these stocks?